FAM54A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.924200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.229800E-01
Normal-vs-Stage2
4.496000E-01
Normal-vs-Stage3
7.359200E-01
Normal-vs-Stage4
9.831200E-01
Stage1-vs-Stage2
3.529200E-01
Stage1-vs-Stage3
6.637400E-01
Stage1-vs-Stage4
8.962200E-01
Stage2-vs-Stage3
2.391600E-01
Stage2-vs-Stage4
3.719200E-01
Stage3-vs-Stage4
7.353600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.913200E-01
Normal-vs-AfricanAmerican
8.575400E-01
Normal-vs-Asian
3.282600E-01
Caucasian-vs-AfricanAmerican
4.486400E-01
Caucasian-vs-Asian
9.760400E-01
AfricanAmerican-vs-Asian
3.405000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.591400E-01
Normal-vs-Female
4.254400E-01
Male-vs-Female
2.647600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.944200E-01
Normal-vs-Age(41-60Yrs)
4.886200E-01
Normal-vs-Age(61-80Yrs)
5.000400E-01
Normal-vs-Age(81-100Yrs)
3.609000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.605000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.493800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.346400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.484200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.589400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.366200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.604600E-01
Normal-vs-Daily Drinker
4.179200E-01
Normal-vs-Weekly Drinker
3.997800E-01
Normal-vs-Occasional Drinker
4.099200E-01
Normal-vs-Social Drinker
5.291400E-01
Non Drinker-vs-Daily Drinker
3.780000E-01
Non Drinker-vs-Weekly Drinker
1.891410E-01
Non Drinker-vs-Occasional Drinker
1.607230E-01
Non Drinker-vs-Social Drinker
8.285600E-01
Daily Drinker-vs-Weekly Drinker
3.806600E-01
Daily Drinker-vs-Occasional Drinker
3.698800E-01
Daily Drinker-vs-Social Drinker
5.574600E-01
Weekly Drinker-vs-Occasional Drinker
9.429000E-01
Weekly Drinker-vs-Social Drinker
2.339200E-01
Occasional Drinker-vs-Social Drinker
2.081200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.952200E-01
Normal-vs-Grade 2
6.371000E-01
Normal-vs-Grade 3
6.544800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.108300E-02
Grade 1-vs-Grade 3
8.095900E-02
Grade 1-vs-Grade 4
5.952200E-01
Grade 2-vs-Grade 3
5.308000E-01
Grade 2-vs-Grade 4
6.371000E-01
Grade 3-vs-Grade 4
6.544800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.779800E-01
Normal-vs-NonDiabetic
4.484800E-01
Diabetic-vs-NonDiabetic
3.867200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.185200E-01
Normal-vs-NoPancreatitis
5.283200E-01
Pancreatitis-vs-NoPancreatitis
5.600600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.182200E-01
Normal-vs-N1
4.812000E-01
N0-vs-N1
8.795000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.964950E-01
Normal-vs-TP53-NonMutant
4.317400E-01
TP53-Mutant-vs-TP53-NonMutant
1.572170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
